Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04777617 · ClinicalTrials.gov registry record
Allosure in Simultaneous Pancreas Kidney Transplant
A clinical trial, sponsored by Washington University School of Medicine.
- Terminated
- Registry status
- 13
- Enrollment target
NCT04777617 is a clinical trial that was terminated before completion, run by Washington University School of Medicine. The registered enrollment target is 13 participants.
The verdict
NCT04777617 was terminated before completion, sponsored by Washington University School of Medicine.
- TERMINATED
- Registry status
- 13 participants
- Enrollment target
Study Summary
This study will observe donor derived cell free DNA percentages (via the Allosure test) in combined kidney-pancreas transplant recipients to establish both stable and dysfunctional Allosure assay levels
Interventions
- OTHER DD-cfDNA
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 13 participants |
| Start Date | 2021-02-26 |
| Est. Completion | 2024-07-31 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04777617
The ClinicalTrials.gov registry entry for NCT04777617 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 13 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Washington University School of Medicine, which has 1,502 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which DD-cfDNA is the first listed.
NCT04777617 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04777617 about?
NCT04777617 is a clinical study titled "Allosure in Simultaneous Pancreas Kidney Transplant". This study will observe donor derived cell free DNA percentages (via the Allosure test) in combined kidney-pancreas transplant recipients to establish both stable and dysfunctional Allosure assay levels
What is the current status of trial NCT04777617?
This trial is currently terminated. The enrollment target is 13 participants. The study started on 2021-02-26. Estimated completion is 2024-07-31.
What interventions are being tested in trial NCT04777617?
The interventions under investigation include: DD-cfDNA (OTHER).
Who is sponsoring clinical trial NCT04777617?
This trial is sponsored by Washington University School of Medicine, which has 1,502 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.